date,title,source
Nov-01-18,"Atara Biotherapeutics Announces Presentations Highlighting Robust Off-the-Shelf, Allogeneic T-Cell Immunotherapy Pipeline and Next-Generation CAR T Technologies at the 60th American Society of Hematology (ASH) Annual Meeting and European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2018",GlobeNewswire
Nov-06-18,Atara Biotherapeutics: 3Q Earnings Snapshot,Associated Press
Nov-06-18,Atara Biotherapeutics Announces Third Quarter 2018 Financial Results and Recent Operational Progress,GlobeNewswire
